Application of a new tumor cell motility stimulating factor, PD-I family proteins todiagnosis and treatment of cancer.

新型肿瘤细胞运动刺激因子PD-1家族蛋白在癌症诊断和治疗中的应用。

基本信息

  • 批准号:
    08670177
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

I have cloned two new members belonging to a phosphodiesterase I gene fimily from rat, and designated as PD-Ialpha and-beta. In current study I have cloned human PD-Ialpha and -beta and peroformed further analysis. I have found that human PD-Ialpha is an alternative splicing product of autotaxin, which is a newly found autocrine tumor cell motility-stimulating factor. I examined the expression of human PD-Ialpha/ATX gene in human neuroblastoma tumor tissues, motility stimulating activity of recombinant ATX on neuroblastoma cells, and investigated its transcriptional regulatory mechanism in a human neuroblastoma cell line. PD-Ialpha/ATX gene was expressed in the primary tumor tissues from the neuroblastoma patients at a various extent. This gene is also expressed in a SMS-KAN neuroblastoma cell line. We indentified both isoforms, PD-Ialpha and ATX,in these tumor tissues and SMS-KAN cells. The recombinant ATX stimulated the motility of SMS-KAN cells at low nanomolar concentration. We situated the promoter region, which is essential for its transcription in SMS-KAN cells, at-287 nt to -254 nt by the promoter activity assay. The gel shift assay revealed that there exists a nuclear protein in SMS-KAN cells that binds this region. These new insights about autocrine tumor cell motility-stimulating protein will help us to understand the metastatic mechanism of human neuroblastoma.I have also cloned human PD-Ibeta. PD-Ibeta gene expression was mostly observed in the prostate and uterus. I have also shown that PD-Ialpha and beta are localized to human chromosome 8q24.1 and 6q22, respectively.
本研究从大鼠中克隆了属于磷酸二酯酶I基因家族的两个新成员,分别命名为PD-Ⅰ α和PD-Ⅰ β。在本研究中,我克隆了人PD-1 α和β,并进行了进一步的分析。我发现人PD-I α是自分泌运动因子autotaxin的选择性剪接产物,autotaxin是一种新发现的自分泌肿瘤细胞运动刺激因子。我检测了人PD-1 α/ATX基因在人神经母细胞瘤肿瘤组织中的表达,重组ATX对神经母细胞瘤细胞的运动刺激活性,并研究了其在人神经母细胞瘤细胞系中的转录调控机制。PD-I α/ATX基因在神经母细胞瘤患者的原发肿瘤组织中有不同程度的表达。该基因也在SMS-KAN神经母细胞瘤细胞系中表达。我们在这些肿瘤组织和SMS-KAN细胞中鉴定了PD-I α和ATX两种亚型。重组ATX在低纳摩尔浓度下刺激SMS-KAN细胞的运动。通过启动子活性测定,我们将其在SMS-KAN细胞中转录所必需的启动子区域定位在-287 nt至-254 nt。凝胶迁移实验表明,在SMS-KAN细胞中存在与该区域结合的核蛋白。这些关于自分泌肿瘤细胞运动刺激蛋白的新认识将有助于我们了解人神经母细胞瘤的转移机制。PD-I β基因表达主要见于前列腺和子宫。我还表明,PD-1 α和β分别定位于人类染色体8q24.1和6 q22。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Maeda,T., Nishimura,N., Nakamura,H., Sano,K.: "p21(WAF1/Cip1/Pic1) mRNA is expressed in neuroblastoma cell -" Acta Pediatrica Japonica. 39. 590-594 (1997)
Maeda,T.、Nishimura,N.、Nakamura,H.、Sano,K.:“p21(WAF1/Cip1/Pic1) mRNA 在神经母细胞瘤细胞中表达 -”Acta Pediatrica Japonica。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hasegawa, D., Kojima, S., et al.: "Elevation of the serum Fas ligand in patients with--" Blood. (in press). (1998)
Hasekawa, D.、Kojima, S. 等人:“患者血清 Fas 配体升高——”血液。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sano, K., Goji, J., Kosaka, Y., Nakamura, H., Nakamura, F., and Tatsumi, E: "t (10 ; 12) (q24 ; q15) in a T-cell lymphoblastic lymphoma with myeloid hyperplasia." Cancer Genet.Cytogenet. (in press). (1998)
Sano, K.、Goji, J.、Kosaka, Y.、Nakamura, H.、Nakamura, F. 和 Tatsumi, E:“T 细胞淋巴母细胞淋巴瘤中的 t (10 ; 12) (q24 ; q15)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawagoe, H., Stracke, M.Nakamura, H., Sano, K.: "Expression and transcriptional regulation of PD-Ia/autotaxin--" Cancer Research. 57. 2516-2521 (1997)
Kawagoe, H.、Stracke, M.Nakamura, H.、Sano, K.:“PD-Ia/自分泌运动因子的表达和转录调控——”癌症研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Maeda, T., Nishimura, N., Nakamura, H., and Sano, K.: "p21 (WAF1/Cip1/Sdi1/Pic1) mRNA is expressed in neuroblastoma cell lines but not in Ewing's sarcoma and primitive neuroectodrmal tumor cell lines." Acta.Paed.Jap.39. 590-594 (1997)
Maeda, T.、Nishimura, N.、Nakamura, H. 和 Sano, K.:“p21 (WAF1/Cip1/Sdi1/Pic1) mRNA 在神经母细胞瘤细胞系中表达,但在尤文氏肉瘤和原始神经外胚层肿瘤细胞系中不表达
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SANO Kimihiko其他文献

SANO Kimihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SANO Kimihiko', 18)}}的其他基金

Structure and function of a new member of ectophosphodiesterase I
外切磷酸二酯酶I新成员的结构与功能
  • 批准号:
    12670135
  • 财政年份:
    2000
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relationship between phosphodiesterase I activity and metastatic ability of cancer cells
磷酸二酯酶I活性与癌细胞转移能力的关系
  • 批准号:
    10670142
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了